Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems


Bristol’s Yervoy falls short in prostate cancer study

Bristol-Myers Squibb Co’s immunotherapy drug Yervoy failed to significantly prolong survival among patients with advanced prostate cancer who had previously received chemotherapy, according to limited data from the first late-stage study of the drug for the condition.

Yervoy (ipilimumab) frees the immune system to attack and kill cancer cells by blocking the action of… Bristol’s Yervoy falls short in prostate cancer study   

vattikuti urology institute1 - bladder removal1 - dysuria2 - prostatic calculi1 - hypercalciuria5 - uterine fibroid embolization1 - creatinine2 - kidney damage7 - sex after prostate surgery1 - kidney stone2 - mri scan1 - new england journal of medicine2 - biomarkers1 - cardiovascular problems1 - nocturia10 - external sphincter dyssynergia3 - bladder frequency1 - estradiol deficiency1 - hypokalemia1 - advanced stage1 - radiographic imaging1 - phosphorus1 - dependence1 - risk of diabetes1 - risk of kidney stones1 - sexually transmitted disease1 - suburethral slings1 - rsna1 - dietary phosphate2 - kidney tumours1 -